AmbioPharm has multiple manufacturing suites to produce peptide APIs at gram to kilogram scale by solid phase synthesis, solution phase synthesis, or hybrid solid/solution phase synthesis. AmbioPharm has validated a dedicated manufacturing line for a generic peptide API at kilogram scale scheduled for re-validation and commercial manufacturing at 150-200 kg/year scale (25-50kg batches)

 
 
Website Design by123Triad Web Design